• inquiry
  • access
    • Japanese
    • English
    • 한국어
    • 簡体中文
    • 繁體中文
This page does not support translation languages. ×
Kimihito Tashima Kimihito Tashima

Kimihito Tashima

TASHIMA Kimihito

Professor

area of expertise: Pharmacology

Main subjects

Pharmacology II, Pharmacology III, Global Pharmacy Training, Introduction to Health Science, Medical Pharmacy Practice 1

Research theme/keyword

・Study on development of functional dyspepsia disease model animals and elucidation of therapeutic targets ・Study on temperature-sensitive channel TRPA1 and gastrointestinal function regulation

Final academic background/degree

Kyoto Pharmaceutical University / Doctor

licence · Qualification

Pharmacist, Pharmacology Educator

Affiliated academic society

The Japanese Ulcer Society, The Japanese Pharmacological Society, The Pharmaceutical Society of Japan, The Japanese Society of Chinese Medicine, The Japanese Society of Neurogastroenterology, The American Society of Gastroenterology

Major achievements

1. N. Ohashi, K. Tashima, T. Namiki, S. Horie. Allyl isothiocyanate, an activator of TRPA1, increases gastric mucosal blood flow through calcitonin gene-related peptide and adrenomedullin in anesthetized rats. J Pharmacol Sci. ), 187-194 (2023).
2. M. Yoshikubo, K. Tashima, M. Raimura, Y. Watanabe, Y. Noma, S. Horie. Daikenchuto, a Traditional Kampo Medicine, Facilitates Mucosal Hyperemic Responses through Activation of TRPA1- and TRPV1-Expressing Sensory Nerves in Rat Stomach. Planta Medica International Open 9(01) e72-e79 (2022).
3. K. Hashimoto, K. Tashima, T. Imai, K. Matsumoto, S. Horie. The rodent model of impaired gastric motility induced by allyl isothiocyanate, a pungent ingredient of wasabi, to evaluate therapeutic agents for functional dyspepsia. J Pharmacol Sci. 145(1), 122-129 (2021).

Click here for detailed research results

extracurricular activities

Part-time Lecturer Faculty of Nursing Tokyo University of Information Sciences

message

Why don't you learn pharmacy at our university and work hard in the world? We support such challenges.